Global Hemophilia B Market 2015-2019 - Industry Analysis
| Published: Sep 2015 | Pages: 60 | SKU: IRTNTR7234 |
Market outlook of the global hemophilia B market
Hemophilia B, commonly known as Christmas disease, is a genetic blood coagulation disorder that is caused due to factor IX deficiency. Even though this is an inherited disease, approximately one-third of the cases occur due to spontaneous gene mutation. Analysts estimate the market for hemophilia B to surpass US$ 2 billion due to the advent of plasma-derived and recombinant factor replacement therapeutics.
Technavio’s market research analysts estimate the Americas to account for approximately 44% of the total market revenue during the forecast period. This region’s domination of the market can be attributed to the increase in prophylactic treatment and development of long-acting hemophilia B therapeutic products.
Competitive landscape and key vendors
The launch of long-acting drugs for factor replacement therapies and its acceptance among the end users is expected to drive market growth by augmenting the revenues generated by companies. Competitiveness in this market is expected to deepen with an increase in strategic alliances and technological advancements.
Leading vendors in this market are –
- Baxter
- Grifols
- Novo Nordisk
- Pfizer
Other prominent vendors in this market are Alnylam Pharmaceuticals, Amarna Therapeutics, Asklepios, Biogen, Catalyst Biosciences, CSL Behring, Dimension Therapeutics, Dong-A Socio, Emergent BioSolutions, Kedrion, OPKO Health, rEVO Biologics, Sangamo BioSciences, Spark Therapeutics, Swedish Orphan Biovitrum, and uniQure.
Segmentation by disease severity and analysis of the hemophilia B market
- Mild hemophilia B
- Moderate hemophilia B
- Severe hemophilia B
The moderate hemophilia B segment accounts for approximately 37% of the total market size and is expected to dominate over the other two segments during the forecast period. In moderate hemophilia B, the activity of factor IX is in the range of 1 to 5% and maybe associated with bleeding episodes after injuries.
Disease-management segmentation of the hemophilia B market
- On-demand therapy
- Prophylaxis
- Inhibitors
In this market research report, analysts estimate the on-demand therapy segment to account for more than 80% of the total market share. The on-demand therapy is widely popular in developing economies like APAC and EMEA, where access to proper healthcare facilities is limited. Also, low awareness pertaining to disease prophylaxis is another factor that is expected to promote the implementation of on-demand treatments in these regions.
Key questions answered in the report include
- What will the market size and the growth rate be in 2019?
- What are the key factors driving the global hemophilia B market?
- What are the key market trends impacting the growth of the global hemophilia B market?
- What are the challenges to market growth?
- Who are the key vendors in the global hemophilia B market?
- What are the market opportunities and threats faced by the vendors in the global hemophilia B market?
- Trending factors influencing the market shares of the EMEA, Americas, and APAC?
- What are the key outcomes of the five forces analysis of the global hemophilia B market?
Technavio also offers customization on reports based on specific client requirement.
Related reports
Global Hemophilia Market 2014-2018
Global Healthcare IT Spending - Market Analysis 2015-2019
Global Preimplantation Genetic Diagnosis (PGD) Market 2014-2018
- Highlights
- Market overview
- Top-vendor offerings
- Research methodology
- Economic indicators
- Key market highlights
- Market overview
- Market size and forecast
- Five forces analysis
- Understanding the disease
- Epidemiology
- Key information of few pipeline candidates
- Mild hemophilia B
- Moderate hemophilia B
- Severe hemophilia B
- On-demand therapy
- Prophylactic therapy
- Inhibitor therapy
- Focus on prophylactic treatment
- Drugs with prolonged action
- Patient assistance programs
- High cost of therapy
- Low diagnosis rate in developing countries
- Complications of available therapies
- Advances in technology
- Strategic alliances
- Development of gene therapy products
- Competitive scenario
- Mergers and acquisitions
- Market share analysis 2014
- Other prominent vendors
- Baxter
- Grifols
- Novo Nordisk
- Pfizer
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis